Kiromic Biopharma, Inc. Proceeds from Stock Options Exercised
Kiromic Biopharma, Inc. reported Proceeds from Stock Options Exercised of $125.40 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-04-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-04-17
- Kiromic Biopharma, Inc. proceeds from stock options exercised for the quarter ending 2021-12-31 was $0.00.
- Kiromic Biopharma, Inc. proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00.
- Kiromic Biopharma, Inc. proceeds from stock options exercised for the quarter ending 2019-12-31 was $1.90K.
- Kiromic Biopharma, Inc. proceeds from stock options exercised for fiscal 2021 was $125.40K.
- Kiromic Biopharma, Inc. proceeds from stock options exercised for fiscal 2019 was $11.40K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $0.00 derived: sum of 2 quarters · filed 2023-04-17 | $125.40K 10-K · filed 2023-04-17 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $125.40K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $125.40K 10-Q · filed 2022-08-12 | |||
| 2019-12-31 | $1.90K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $11.40K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $9.50K 10-Q · filed 2020-11-30 |